At the mRNA level, we found that CLDN11 and CLDN4 expression were respectively reduced and increased in CRC tumor samples relative to paracancerous controls as measured via qPCR (n = 10, p < 0.05). The gene discussed is CLDN4; the disease is neoplasm.